Inova Heart and Vascular Institute, Falls Church, Virginia.
Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
JACC Heart Fail. 2019 Nov;7(11):913-921. doi: 10.1016/j.jchf.2019.07.001. Epub 2019 Aug 7.
The development of treatments for heart failure (HF) is challenged by burdensome clinical trials. Reducing the need for extensive data collection and increasing opportunities for data compatibility between trials may improve efficiency and reduce resource burden. The Heart Failure Collaboratory (HFC) multi-stakeholder consortium sought to create a lean case report form (CRF) for use in HF clinical trials evaluating cardiac devices. The HFC convened patients, clinicians, clinical researchers, the U.S. Food and Drug Administration (FDA), payers, industry partners, and statisticians to create a consensus core CRF. Eight recent clinical trial CRFs for the treatment of HF from 6 industry partners were analyzed. All CRF elements were systematically reviewed. Those elements deemed critical for data collection in HF clinical trials were used to construct the final, harmonized CRF. The original CRFs included 176 distinct data items covering demographics, vital signs, physical examination, medical history, laboratory and imaging testing, device therapy, medications, functional and quality of life assessment, and outcome events. The resulting, minimally inclusive CRF device contains 75 baseline data items and 6 events, with separate modular additions that can be used depending on the additional detail required for a particular intervention. The consensus electronic form is now freely available for use in clinical trials. Creation of a core CRF is important to improve clinical trial efficiency in HF device development in the United States. This living document intends to reduce clinical trial administrative burden, increase evidence integrity, and improve comparability of clinical data between trials.
心力衰竭 (HF) 治疗方法的开发面临着临床试验负担过重的挑战。减少对广泛数据收集的需求,并增加试验之间数据兼容性的机会,可能会提高效率并减轻资源负担。心力衰竭协作组 (HFC) 多利益相关者联盟旨在为评估心脏设备的心力衰竭临床试验创建精简的病例报告表 (CRF)。HFC 召集了患者、临床医生、临床研究人员、美国食品和药物管理局 (FDA)、支付方、行业合作伙伴和统计学家,以创建共识核心 CRF。分析了来自 6 家行业合作伙伴的最近 8 项用于治疗 HF 的临床试验 CRF。对所有 CRF 元素进行了系统审查。那些被认为对 HF 临床试验数据收集至关重要的元素被用于构建最终的、协调一致的 CRF。原始 CRF 包括 176 个不同的数据项,涵盖人口统计学、生命体征、体格检查、病史、实验室和影像学检查、设备治疗、药物、功能和生活质量评估以及结果事件。由此产生的最小包容性 CRF 设备包含 75 个基线数据项和 6 个事件,还有单独的模块化附加项,可以根据特定干预措施所需的额外详细信息进行使用。共识电子表格现在可免费用于临床试验。在美国,创建核心 CRF 对于改善 HF 设备开发临床试验的效率非常重要。这份活文档旨在减轻临床试验的行政负担,提高证据完整性,并提高试验之间临床数据的可比性。